Cover

​​Novel approach: The success of COVID-19 vaccines is leading to a greater focus on next-generation therapies. Also, how sustainability is rapidly climbing the pharma corporate agenda and why psychedelic drugs may be able to establish a therapeutic future.

March 2022 - PharmaTimes

Issues

Online Media Hub

PharmaTimes Magazine

PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.

https://pharmatimes.com/

PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.

NOVEL THERAPIES